Screener
Recursion Pharmaceuticals, Inc. RXRX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$131.01M+23.8% | -$117.5M+42.0% | -$108.12M+39.6% | -$162.25M-69.3% | -$171.9M-76.2% | ||
| $18.17M-23.8% | $19.67M+1.8% | $19.48M+50.4% | $21.04M+192% | $23.85M+166% | ||
| $19.5M-25.5% | $22.22M-38.4% | $23.76M-22.8% | $25.24M+38.3% | $26.16M+58.3% | ||
| -$105.95M-38.6% | -$81.1M+38.5% | -$46.07M+60.1% | -$117.36M-98.2% | -$76.42M+7.1% | ||
| $44K-98.6% | $258K-85.9% | $1.24M-4.2% | $243K-94.7% | $3.15M+166% | ||
| -$1.96M+66.3% | -$338K+95.4% | -$1.24M-100% | -$2.55M+44.1% | -$5.81M-38.9% | ||
| $2.25M+8.0% | $2.21M+7.9% | $2.17M+3.1% | $2.13M-7.0% | $2.08M+7,915% | ||
| -$1.27M-101% | -$3.47M-109% | $132.01M+1,141% | $251.34M+1,427% | $97.66M-62.9% | ||
| -$108.36M-539% | -$88.74M+5.5% | $86.78M-48.1% | $133.3M— | $24.69M-86.0% | ||
| -$105.99M-33.2% | -$81.36M+39.2% | -$47.32M+59.5% | -$117.6M-84.4% | -$79.57M+4.6% |
FAQ
- How much cash does Recursion Pharmaceuticals, Inc. generate?
- Recursion Pharmaceuticals, Inc. (RXRX) generated -$350.5M in operating cash flow over the trailing twelve months.
- What is Recursion Pharmaceuticals, Inc.'s free cash flow?
- After $1.8M of capital expenditures, Recursion Pharmaceuticals, Inc.'s free cash flow was -$352.3M over the trailing twelve months, up 10.6% year over year.
- Where does Recursion Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Recursion Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
